🇺🇸 MRK — Merck & Co., Inc.
Healthcare CompraPrecio actual
150,33 USD
Máx. histórico
156,92
10 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-4,20%
Rango 52 semanas
77,58 – 156,92
Variación hoy
-1,32%
Cierre anterior
152,34
Rango de hoy
150,09 – 152,22
Volumen hoy
4.298.143
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Healthcare
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 120,26 (puede no estar actualizado)
- Dividend yield
- 2,23% (puede no estar actualizado)
- Precio objetivo analistas
- 149,50 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 3 días
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 12/03/2015 | 0,4294 USD |
| 11/12/2014 | 0,4294 USD |
| 11/09/2014 | 0,4198 USD |
| 12/06/2014 | 0,4198 USD |
| 13/03/2014 | 0,4198 USD |
| 12/12/2013 | 0,4198 USD |
| 12/09/2013 | 0,4103 USD |
| 13/06/2013 | 0,4103 USD |
| 13/03/2013 | 0,4103 USD |
| 13/12/2012 | 0,4103 USD |
| 13/09/2012 | 0,4008 USD |
| 13/06/2012 | 0,4008 USD |
| 13/03/2012 | 0,4008 USD |
| 13/12/2011 | 0,4008 USD |
| 13/09/2011 | 0,3626 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/02/1992 | 24,33 | 24,37 | 23,91 | 24,01 | -1,71% | 1,88% | 4.267.037 |
| 12/02/1992 | 24,35 | 24,53 | 24,21 | 24,43 | -0,16% | 1,31% | 4.012.373 |
| 11/02/1992 | 24,47 | 24,55 | 24,31 | 24,47 | +0,08% | 0,97% | 3.052.824 |
| 10/02/1992 | 24,41 | 24,69 | 24,41 | 24,45 | +0,16% | 1,14% | 3.549.576 |
| 07/02/1992 | 24,89 | 24,93 | 24,29 | 24,41 | -1,60% | 2,56% | 4.343.122 |
| 06/02/1992 | 25,07 | 25,09 | 24,53 | 24,81 | -1,34% | 2,22% | 4.997.074 |
| 05/02/1992 | 25,43 | 25,58 | 25,03 | 25,15 | -0,47% | 2,19% | 7.341.240 |
| 04/02/1992 | 24,51 | 25,27 | 24,51 | 25,27 | +2,92% | 3,08% | 5.639.078 |
| 03/02/1992 | 25,01 | 25,23 | 24,49 | 24,55 | -1,75% | 2,94% | 5.796.907 |
| 31/01/1992 | 24,87 | 25,19 | 24,85 | 24,99 | +1,21% | 1,36% | 5.165.592 |
| 30/01/1992 | 24,31 | 24,73 | 24,23 | 24,69 | +1,89% | 2,04% | 4.285.901 |
| 29/01/1992 | 24,33 | 24,93 | 24,17 | 24,23 | -0,41% | 3,10% | 7.614.139 |
| 28/01/1992 | 24,13 | 24,49 | 23,95 | 24,33 | +0,66% | 2,22% | 5.528.410 |
| 27/01/1992 | 24,49 | 24,55 | 24,09 | 24,17 | -0,98% | 1,87% | 4.396.570 |
| 24/01/1992 | 24,61 | 24,81 | 24,39 | 24,41 | -0,97% | 1,70% | 5.612.669 |
| 23/01/1992 | 24,73 | 25,01 | 24,57 | 24,65 | +0,08% | 1,77% | 6.201.854 |
| 22/01/1992 | 24,09 | 24,63 | 24,07 | 24,63 | +2,23% | 2,31% | 5.188.229 |
| 21/01/1992 | 24,47 | 24,47 | 23,70 | 24,09 | -1,30% | 3,17% | 6.626.294 |
| 20/01/1992 | 24,49 | 24,69 | 24,37 | 24,41 | -0,16% | 1,30% | 5.531.554 |
| 17/01/1992 | 24,03 | 24,45 | 24,03 | 24,45 | -0,24% | 1,74% | 12.345.859 |
| 16/01/1992 | 24,05 | 24,61 | 23,91 | 24,51 | -1,28% | 2,89% | 14.335.382 |
| 15/01/1992 | 25,47 | 25,49 | 24,73 | 24,83 | -2,50% | 2,97% | 9.079.872 |
| 14/01/1992 | 25,41 | 25,50 | 25,05 | 25,47 | +0,00% | 1,80% | 7.145.683 |
| 13/01/1992 | 25,88 | 25,90 | 25,29 | 25,47 | -1,76% | 2,38% | 6.233.923 |
| 10/01/1992 | 26,34 | 26,44 | 25,88 | 25,92 | -2,10% | 2,11% | 4.049.472 |
| 09/01/1992 | 26,54 | 26,60 | 26,28 | 26,48 | -0,15% | 1,20% | 4.712.227 |
| 08/01/1992 | 26,44 | 26,66 | 26,40 | 26,52 | +0,00% | 0,98% | 4.663.181 |
| 07/01/1992 | 26,48 | 26,54 | 26,36 | 26,52 | -0,30% | 0,68% | 3.459.029 |
| 06/01/1992 | 26,84 | 26,90 | 26,46 | 26,60 | -0,96% | 1,63% | 5.682.466 |
| 03/01/1992 | 26,34 | 27,00 | 26,34 | 26,86 | +1,50% | 2,49% | 4.809.062 |